Enzon Pharmaceuticals's total assets for Q1 2025 were $45.52M, a decrease of -3.49% from the previous quarter. ENZN total liabilities were $43.57M for the fiscal quarter, a -1.34% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.